Faisel Khan

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:dundee.ac.uk

Faisel Khan, PhD, is a Professor of Cardiovascular Sciences, School of Medicine, University of Dundee, UK, and Honorary Clinical Scientist with NHS Tayside, Dundee, UK.

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Spence, VA; Khan, F; Kennedy, G; Abbot, NC; Belch, JJ (2004), "Acetylcholine mediated vasodilatation in the microcirculation of patients with chronic fatigue syndrome", Prostaglandins, leukotrienes, and essential fatty acids, 70 (4): 403-7, doi:10.1016/j.plefa.2003.12.016 
  2. Khan, Faisel; Kennedy, Gwen; Spence, Vance A.; Newton, David J.; Belch, Jill J. F. (2004), "Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure", Clinical Science, 106 (2): 183-189, doi:10.1042/CS20030246 
  3. Kennedy, Gwen; Khan, Faisel; Hill, Alexander (2010), "Biochemical and Vascular Aspects of Pediatric Chronic Fatigue Syndrome", Arch Pediatr Adolesc Med, 164 (9): 817-823, doi:10.1001/archpediatrics.2010.157 
  4. Newton, David J.; Kennedy, Gwen; Chan, Kenneth K.F.; Lang, Chim C.; Belch, Jill J.F.; Khan, Faisel (2012), "Large and small artery endothelial dysfunction in chronic fatigue syndrome", International Journal of Cardiology, 154 (3): 335–336, doi:10.1016/j.ijcard.2011.10.030 
  5. Witham, Miles; Kennedy, Gwen; Belch, Jill; Hill, Alexander; Khan, Faisel (2014), "Association between vitamin D status and markers of vascular health in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)", International Journal of Cardiology, 174 (1): 139 - 140, doi:10.1016/j.ijcard.2014.03.145 
  6. Khan, F.; Belch, J. J. F.; Kabir, G.; Kennedy, G.; McSwiggan, S.; Adams, F.; Witham, M. D. (Mar 1, 2015). "Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome – A randomised controlled trial". Nutrition, Metabolism and Cardiovascular Diseases. 25 (3): 287–294. doi:10.1016/j.numecd.2014.10.007. ISSN 1590-3729. PMID 25455721. 
  7. Witham, MD; Adams, F; McSwiggan, S; Kennedy, G; Kabir, G; Belch, JJ; Khan, F (2015), "Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome – A randomised controlled trial", Nutrition, Metabolism and Cardiovascular Diseases, 25 (3): 287-294, doi:10.1016/j.numecd.2014.10.007 

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

randomized controlled trial (RCT) - A trial in which participants are randomly assigned to two groups, with one group receiving the treatment being studied and a control or comparison group receiving a sham treatment, placebo, or comparison treatment.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.